In endometrial cancers, high TMB was enriched in KRAS G13D, G12D, G12C, and G12A (45%, 34%, 30%, and 31%) compared to G12V and WT (21% and 16%, p < 0.05 for all comparisons; Table 1 and Fig. 4a). Here, KRAS is linked to endometrial cancer.